Skip to content
★ Sign in to follow
YZ

Yuan Zhi Jun

Biolidics Limited
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
4
Company
1
▲ Purchases (2 ops.)
—
▼ Sales (1 ops.)
€2.1M

Latest filing published 09 Sept 2025 for BIOLIDICS LIMITED, €2.1M.

Filing timeline

BuySale
Yuan Zhi Jun

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Yuan Zhi Jun: trading record in brief

All filings by Yuan Zhi Jun on record concern Biolidics Limited. Between 7 October 2024 and 9 September 2025, the trades on record add up to 4 filings.

Both buying and selling appear: 2 purchases, against 1 sale worth €2.1M. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 1 purchase and 1 sale.

Most recently, on 9 September 2025, the filings show an open-market sale worth €2.1M in Biolidics Limited. The latest purchase dates back some time: it was published 457 days ago, on 8 August 2025. This summary is built from SGX disclosures alone and does not predict where the share price will go.

Companies and markets linked to Yuan Zhi Jun

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▼
    Substantial ShareholderExecutives(filed)Biolidics Limited
    3M SGD13SGX
    148,391,600 shares@ SGD 0.021100.0% of flowShareSGX-STISIN SGXE89830751SGX:2PMGH3F2OWVE0HKN
  • ▲
    Substantial ShareholderExecutives(filed)Biolidics Limited
    0SGX
    35,000,000 sharesShareSGX-STISIN SGXE89830751SGX:ME5JVJ1OK20FVADI
    Canonical exit: 6 Nov 2025 (T+90)
  • ●
    Substantial ShareholderExecutives(filed)Biolidics Limited
    0SGX
    148,391,600 sharesShareSGX-STISIN SGXE89830751SGX:Q2WFK2I7Y5Q0TL5M
  • ▲
    Substantial ShareholderExecutives(filed)Biolidics Limited
    0SGX
    148,391,600 sharesShareSGX-STISIN SGXE89830751SGX:YADPN4MJDAM11JRA
    Canonical exit: 5 Jan 2025 (T+90)

4 of 4 declarations